Saroja Pharma Industries India Ltd (SAROJA) is currently trading at N/A per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Saroja Pharma Industries India Limited is primarily engaged in providing pharmaceutical services, focusing on the trade of Active Pharmaceutical Ingredients (API), Pharma Intermediates, and other chemical products used in human and veterinary medicine. The company has recently transitioned from a private to a public limited entity, intending to leverage its new structure to access broader market opportunities and increase its investor base. Saroja Pharma is planning a public issue of equity shares to raise capital, indicating a strategic intent to fuel further growth and expansion in the pharmaceutical sector. The company has witnessed significant growth in its client base over the past two years, suggesting a strong market presence and demand for its offerings. Founders Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble are focused on global integration and innovation, positioning the company as a reputable player in the global healthcare landscape.

Over the past 52 weeks, Saroja Pharma Industries India Ltd has traded between a low of ₹28.00 and a high of ₹48.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Saroja Pharma Industries India Ltd has a market capitalization of approximately 16.44. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Saroja Pharma Industries India Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 10.21 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 16.44 Cr, Saroja Pharma Industries India Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Saroja Pharma Industries India Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Saroja Pharma Industries India Ltd is 10.21. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.